Variant report
Variant | esv2550392 |
---|---|
Chromosome Location | chr4:98424040-98425746 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190346802 | chr4:98424063-98424064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547489987 | chr4:98424077-98424078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77633438 | chr4:98424079-98424080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539401370 | chr4:98424110-98424111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551094292 | chr4:98424208-98424209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183017865 | chr4:98424333-98424334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569931881 | chr4:98424344-98424345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113009387 | chr4:98424393-98424394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192366563 | chr4:98424415-98424416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544133629 | chr4:98424504-98424505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534530097 | chr4:98424566-98424567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575940951 | chr4:98424583-98424584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112718369 | chr4:98424591-98424592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368874971 | chr4:98424622-98424623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78973765 | chr4:98424645-98424646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376721288 | chr4:98424654-98424655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563578116 | chr4:98424740-98424741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575882387 | chr4:98424795-98424796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139328584 | chr4:98424839-98424840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561651622 | chr4:98424864-98424865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183930911 | chr4:98424887-98424888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6845428 | chr4:98424901-98424902 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs74211467 | chr4:98425059-98425060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs56927672 | chr4:98425091-98425092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs57778018 | chr4:98425094-98425095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60553957 | chr4:98425101-98425102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs57708726 | chr4:98425104-98425105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60452023 | chr4:98425110-98425111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs59448093 | chr4:98425117-98425118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs59084734 | chr4:98425124-98425125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61612583 | chr4:98425125-98425126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs55723446 | chr4:98425150-98425151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs56032977 | chr4:98425156-98425157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59067477 | chr4:98425157-98425158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs56076949 | chr4:98425163-98425164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192411698 | chr4:98425295-98425296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533108421 | chr4:98425397-98425398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115448451 | chr4:98425442-98425443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569585143 | chr4:98425545-98425546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2865798 | chr4:98425582-98425583 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs548978039 | chr4:98425699-98425700 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567238415 | chr4:98425709-98425710 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535291461 | chr4:98425737-98425738 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:98420400-98425400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr4:98420400-98425400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:98420600-98424600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr4:98420600-98425600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
5 | chr4:98421000-98425600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr4:98421000-98426000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:98422200-98425600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr4:98422400-98428600 | Weak transcription | HMEC | breast |
9 | chr4:98424000-98425400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr4:98424600-98425000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr4:98425000-98425200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr4:98425200-98427000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr4:98425400-98425600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr4:98425400-98426800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr4:98425400-98426800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr4:98425600-98425800 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
17 | chr4:98425600-98426600 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
18 | chr4:98425600-98426800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr4:98425600-98427000 | Enhancers | HUES6 Cell Line | embryonic stem cell |